Skip to main content
Elsevier
View Cart
openUserAccount

Books in Hepatology

BooksJournals
51-60 of 70 results in All results

Portal Hypertension, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 18-2
  • April 4, 2014
  • Jorge Herrera
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 2 9 7 1 1 - 0
  • eBook
    9 7 8 - 0 - 3 2 3 - 2 9 7 1 2 - 7
Dr. Herrera has created an issue that will serve as a complete update on the topic of Portal Hpertension. Content is provided from medical therapies to surgery on the patient with portal hypertension. The following important issues are addressed: Invasive and Noninvasive Methods of Measuring Portal Pressure; Primary Prophylaxis of Varceal Bleeding; Gastric and Ectopic Varices; Hepatic Hydrothorax; and Hepatopulmonary Syndrome. Readers will come away with state-of-the-art information on the topic of portal hypertension.

The Impact of Obesity and Nutrition on Chronic Liver Diseases, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 18-1
  • December 2, 2013
  • Zobair Younossi
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 2 6 6 6 4 - 2
  • eBook
    9 7 8 - 0 - 3 2 3 - 2 6 6 6 5 - 9
Internationally renowned experts present topics related to obesity, nutrition, and liver disease in this issue. In the first article, the epidemiology of obesity and its association with liver disease are covered. The following two articles focus on the roles that visceral adipose tissue and microbiota potentially play in the pathogenesis of obesity-related liver disease. The next article focuses on the hepatic pathology seen in patients with obesity-related liver disease and those with malnutrition. The next five articles are focused on NAFLD and provide in-depth data on the natural history and treatment strategies for patients with NAFLD. The next six articles deal with the impact of obesity on other liver diseases and on special populations including children and liver-transplant recipients. The final article provides the most updated information regarding genomics and genetic targets that may provide better prognostic and diagnostic biomarkers and more personalized treatment targets for patients with NAFLD. Cutting-edge information in this issue will help readers gain better understanding of the natural history and pathogenesis of primary and secondary liver diseases associated with obesity. As the information about obesity-related liver disease expands, clinicians will be able to provide more targeted therapeutic options for these patients and develop more accurate diagnostic and prognostic biomarkers.

Drug Hepatotoxicity, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 17-4
  • October 16, 2013
  • Nicholaos Pyrsopoulos
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 2 6 1 0 6 - 7
  • eBook
    9 7 8 - 0 - 3 2 3 - 2 6 1 0 7 - 4
Dr. Pyrsopolous has created a comprehensive review on the most important and timely topics in drug heptatotoxicity. He has arraanged for there to be a full span of very basic articles that discuss drug metabolism, hepatotoxicity, and drug-induced acute liver failure as well as other important articles devoted to clinical manifestations and treatment of drug induced hepatotoxicity; Pathological manifestations of drug induced hepatotoxicity; Drug induced cholestasis; Lipid lowering agents induced hepatotoxicity; Herbal ,complementary and alternative medicine induced liver injury; Antiretroviral and anti - HCV DAA related hepatotoxicity; Antibiotic related hepatotoxicity; Acetaminophen related hepatoxicity; NSAIDS induced hepatoxocity; Chemotherapy induced hepatotoxicity; Anti epileptic induced hepatotoxicity; and steatohepatitis induced by drugs.

Hepatitis B Virus, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 17-3
  • August 28, 2013
  • Tarik Asselah + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 1 8 6 0 8 - 7
  • eBook
    9 7 8 - 0 - 3 2 3 - 1 8 6 2 7 - 8
The Guest Editors have assembled top international experts to present clinical reviews on the most current data being utilized in the diagnosis, treatment, and management of HBV. In fact, the most recent EASL meeting fndings are included in many of the articles. Special focus is given to Results of Treatment of Chronic Hepatitis B with Pegylated Interferon; Impact of Therapy on the Long Term Outcome of Chronic Hepatitis B; HBsAg Quantification: Clinical; HBV Infection and Hepatocellular Carcinoma; HIV-HBV Co-Infection: An Update; Hepatitis Delta: The Rediscovery; and Treatment of Patients with HBV Related Decompensated Cirrhosis and Liver Transplanted Patients.

A Practical Approach to the Spectrum of Alcoholic Liver Disease, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 16-4
  • October 29, 2012
  • David Bernstein
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 4 9 1 7 - 1
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 4 7 3 7 - 5
The Guest Editor has organized this issue to focus on the clinical management of alcoholic liver disease. Authors have written state-of-the-art reviews on the following topics: Prevalence and Natural History of ALD; Alcohol Metabolism; Immunology in ALD; Histological Findings in ALD; Diagnosis and Management of Alcoholic Hepatitis; Management of Alcohol Abuse; Long Term Management of Alcoholic Liver Disease; Infections in ALD; Nutrition in ALD; Alcohol’s Effect on Other Chronic Liver Diseases; Liver Cancer and Alcohol; Evaluation and Selection of Candidates for Liver Transplantation; and ALD and Specific Transplant-Related Issues.

Nonalcoholic Fatty Liver Disease, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 16-3
  • August 8, 2012
  • Arun J. Sanyal
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 4 9 1 6 - 4
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 4 7 3 6 - 8
Dr. Sanyal's expertise as Chairman of the Division of Hepatology at Virginia Commonwealth University and the breadth of his published articles in hepatology make him the perfect person to compile state-of-the-art reviews on the topic of NASH/fatty liver. The articles in this issue address the following topics: The Genetic Epidemiology of Nonalcoholic Fatty Liver Disease; Relevance of Liver Histology to Predict Clinically Meaningful Outcomes in NASH; Mechanisms of Simple Hepatic Steatosis; Cellular and Molecular Basis for Phenotype of Steatohepatitis; Mechanisms of Disease Progression in NASH: New Paradigms; Can NASH Be Diagnosed, Graded and Staged Non-Invasively?; Is NAFLD in Children the Same Disease as in Adults?; The Cardiovascular Link to NAFLD: A Critical Analysis; Impact of Behavioral Disturbances and Their Treatment on Obesity and NAFLD; and Management of NASH.

Approach to Consultations for Patients with Liver Disease, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 16-2
  • May 28, 2012
  • Steven L. Flamm
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 3 8 8 6 - 1
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 4 4 1 3 - 8
With very much success in 2009, this topic is being updated again in 2012. Dr. Flamm has invited a group of distinguished hepatologists to provide insight into the assessment of a variety of scenarios where clinical judgment based on experience and published literature is an invaluable addition to the care of individual patients. Articles included in the issue address the following topics: Evaluatio of Elevated Liver Enzymes and Abnormal Liver Panel; Evaluation of Liver Lesions; Chronic HCV; Evaluation of Hepatic Cholestasis; Chronic HBV; Ascites; Fatty Liver; Pruritus in the patient with chronic cholestatic liver disease; Is the patient a candidate for liver transplantation; Care of the cirrhotic patient; Abnormal liver panel in pregnancy; Surgical clearance for the patient with chronic liver disease; Granulomatous Liver Disease; Drug Induced Liver Disease; and Hepatic Encephalopathy.

Liver Transplant: Reaching the half century, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 15-4
  • November 14, 2011
  • Paul Martin + 1 more
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 1 1 0 8 - 6
World-renown expert, Dr. Paul Martin, has assembled an impressive list of authors to update the important topic of orthotopic liver transplantation. The issue provides comprehensive clinical coverage on this topics as articles are focused from the care of the pre-transplant patient to the care of the post-transplant patient. Content also covers the following topics: Transplantation for Hepatocellular Carcinoma; Transplantation for Cholangiocarcinoma; Management of Renal Dysfunction in Liver Transplant Patients; Expanded Donors in Liver Transplantation; Current Status of Liver Transplantation for HBV; MELD: End of the First Decade; and Management of Recurrent HCV Infection.

Hepatitis C Direct Acting Antivirals: The New Standard of Care, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 15-3
  • September 23, 2011
  • Fred Poordad
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 1 1 0 7 - 9
Hepatitis C Virus is a quickly evolving area within hepatology owing to new medical therapies. This issue, guest edited by Dr. Fred Poordad, includes the most current clinical information and treatment therapies. Expert authors have written review articles devoted to the following medical therapies: Boceprevir, Telaprevir, Protease Inhibitors in Development, NS5B Nucleoside and Non-Nucleoside Inhibitors. Review articles also address important patients like naïve- and non-responders and relapsers, the HIV co-infected patient, and the Genotype 1 and non-Genotype 1 patient.

Diagnosis and Therapy of Hepatocellular Carcinoma: Status Quo and a Glimpse at the Future, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 15-2
  • May 28, 2011
  • Adrian Reuben
  • English
  • Hardback
    9 7 8 - 1 - 4 5 5 7 - 0 4 6 5 - 1
  • eBook
    9 7 8 - 1 - 4 5 5 7 - 1 2 3 7 - 3
Dr. Adrian Reuben updates one of the most highly requested topics in liver disease by inviting highly distinguished authors to address the important aspects of diagnosis and treatment of hepatocelluar carcinoma. State-of-the-art issues are addressed, including the role of oncogenic viruses, molecular and genetic guidelines, and screening and staging. Dr. Reuben, himself, concludes the issue with an important article on an agorithmic approach to diagnosis and treatment: Resect, Ablate, Replace or Intoxicate?